PMID: 9545432May 23, 1998Paper

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase

Chemistry & Biology
J H ToneyG G Hammond

Abstract

High level resistance to carbapenem antibiotics in gram negative bacteria such as Bacteroides fragilis is caused, in part, by expression of a wide-spectrum metallo-beta-lactamase that hydrolyzes the drug to an inactive form. Co-administration of metallo-beta-lactamase inhibitors to resistant bacteria is expected to restore the antibacterial activity of carbapenems. Biphenyl tetrazoles (BPTs) are a structural class of potent competitive inhibitors of metallo-beta-lactamase identified through screening and predicted using molecular modeling of the enzyme structure. The X-ray crystal structure of the enzyme bound to the BPT L-159,061 shows that the tetrazole moiety of the inhibitor interacts directly with one of the two zinc atoms in the active site, replacing a metal-bound water molecule. Inhibition of metallo-beta-lactamase by BPTs in vitro correlates well with antibiotic sensitization of resistant B. fragilis. BPT inhibitors can sensitize a resistant B. fragilis clinical isolate expressing metallo-beta-lactamase to the antibiotics imipenem or penicillin G but not to rifampicin.

References

Sep 1, 1992·Obstetrics and Gynecology Clinics of North America·M J Dinsmoor
Sep 1, 1991·Journal of Medicinal Chemistry·N B MantloC S Sweet
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·S MitsuhashiM Inoue
Jan 1, 1985·Methods in Enzymology·W A Hendrickson
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Aug 20, 1971·Biochimica Et Biophysica Acta·C HarperB J Campbell
Jan 1, 1980·The Journal of Membrane Biology·C L Welch, B J Campbell
Jan 1, 1994·Methods in Enzymology·M D MillerD J Underwood
Oct 1, 1994·Journal of Computer-aided Molecular Design·S K KearsleyM D Miller
Apr 1, 1994·Journal of Computer-aided Molecular Design·M D MillerR P Sheridan
Jan 1, 1994·The Journal of Antimicrobial Chemotherapy·H de LencastreA Tomasz
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B A RasmussenF P Tally
Feb 1, 1996·Journal of Chemotherapy·M Hedberg, C E Nord
Nov 1, 1996·Chemistry & Biology·J R KnoxJ M Frere
Jan 1, 1997·Antimicrobial Agents and Chemotherapy·D J PayneJ Marchand-Brynaert
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·B A Rasmussen, K Bush
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Guerrier-TakadaS Altman
Mar 21, 1998·Science·R J Williams, D L Heymann
Oct 8, 1998·Acta Crystallographica. Section D, Biological Crystallography·A CarfiO Dideberg

❮ Previous
Next ❯

Citations

Mar 4, 2000·Archives of Biochemistry and Biophysics·B G GreenS K Grant
Mar 16, 2001·Bioorganic & Medicinal Chemistry·S BounagaM I Page
Jul 25, 2000·Molecular Medicine Today·Y T TanI A McKay
Jan 28, 2003·Drug Discovery Today·Peter W TaylorJ Paul Luzio
Oct 6, 1999·Current Opinion in Chemical Biology·Z WangS J Benkovic
Feb 4, 2010·Journal of Medicinal Chemistry·Peter OelschlaegerJeffrey H Toney
Jul 4, 2001·European Journal of Biochemistry·A ZervosenM Galleni
Jun 10, 2009·Assay and Drug Development Technologies·Peggy A SanchezJohn M Berger
Mar 24, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Jun-ichi WachinoKeigo Shibayama
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·N FranceschiniG M Rossolini
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·M GalleniUNKNOWN Metallo-beta-lactamases Working Group
May 23, 2002·Antimicrobial Agents and Chemotherapy·David J PayneAlfonso Rivera-Sagredo
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Stefan SiemannGary I Dmitrienko
Jan 13, 2010·Clinical Microbiology Reviews·Sarah M Drawz, Robert A Bonomo
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Mar 19, 2014·Future Medicinal Chemistry·Derek A NicholsYu Chen
Jul 19, 2013·Future Medicinal Chemistry·Dustin T King, Natalie C J Strynadka
May 2, 2008·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Adriana Badarau, Michael I Page
Jun 15, 2006·Journal of Computational Chemistry·Guillermina EstiuKenneth M Merz
Nov 21, 2012·Annals of the New York Academy of Sciences·Timothy Palzkill
Jan 18, 2013·Journal of Enzyme Inhibition and Medicinal Chemistry·Zafer Asim KaplancikliUsama Abu Mohsen
Nov 4, 2000·Expert Opinion on Investigational Drugs·D J PayneJ H Bateson
Apr 2, 2015·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Mahesh AithaMichael W Crowder
Apr 9, 2001·The Journal of Pharmacy and Pharmacology·K Poole
Dec 16, 2016·Journal of Medicinal Chemistry·Lai WeiYe Fang
Dec 13, 2016·Journal of Labelled Compounds & Radiopharmaceuticals·Gholamhossein ShirvaniNader Saemian
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·John D BuynakTimothy R Walsh
Dec 28, 2005·Bioorganic & Medicinal Chemistry·Lars OlsenFlemming S Jørgensen
Mar 26, 2004·Organic Letters·Olga KivrakidouNils Griebenow
May 12, 2007·Trends in Molecular Medicine·Gerard D Wright, Arlene D Sutherland
Apr 1, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cheng-Xi WeiGuo-Hua Gong
Sep 21, 2001·The Journal of Biological Chemistry·C MollardG C Roberts
Jun 8, 2001·The Journal of Biological Chemistry·J H ToneyY D Gao
May 14, 2004·The Journal of Biological Chemistry·Rodolfo M Rasia, Alejandro J Vila
May 26, 2004·The Journal of Biological Chemistry·Paola Sandra MercuriMoreno Galleni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.